Provigate is a healthcare organization that develops blood glucose monitoring sensors to prevent diabetes and blood glucose levels.
Provigate has raised $7.8M in total funding. The most recent round was Grant. The last funding was announced in October 2024.
Provigate's investors include UTEC - The University of Tokyo Edge Capital Partners, ANRI, Coral Capital, REVIC, SPARX Group.
Provigate is headquartered in Tokyo, Japan.
Provigate is a healthcare organization that develops blood glucose monitoring sensors to prevent diabetes and blood glucose levels.
Provigate is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Provigate — Funding & Investors." VCBacked, October 28, 2024, https://www.vcbacked.co/company/provigate. Accessed November 13, 2026.
VCBacked. (2024). Provigate — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/provigate
{{cite web |title=Provigate — Funding & Investors |url=https://www.vcbacked.co/company/provigate |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Provigate? Request a listing update